
NVST Stock Forecast & Price Target
NVST Analyst Ratings
Bulls say
Envista Holdings Corp has demonstrated a positive growth trajectory, with implant sales rebounding after a previous decline, showing a marked increase in Premium Implant revenue both globally and in North America. The company recently raised its full-year 2025 core sales growth guidance from a range of 1-3% y/y to 3-4% y/y, reflecting increased confidence in its market positioning. Additionally, the success of its Wires & Brackets segment, which saw sales rise by high single digits year-over-year, further indicates a robust demand for its specialty products and technologies.
Bears say
Envista Holdings Corp reported a minor EBIT miss of $0.02, despite achieving top-line growth, indicating potential operational inefficiencies that could dampen future performance. The company maintained its EBITDA margin guidance at approximately 14% for FY25, suggesting limited improvement in profitability, even with an increase in core sales growth expectations by 150 basis points. Additionally, various risks—including heightened competition, a weakening macroeconomic landscape, and challenges related to commercial execution—present significant headwinds that could negatively impact the company's financial outlook.
This aggregate rating is based on analysts' research of Envista Holdings Corp and is not a guaranteed prediction by Public.com or investment advice.
NVST Analyst Forecast & Price Prediction
Start investing in NVST
Order type
Buy in
Order amount
Est. shares
0 shares